GGrantIndex
← Leaderboards

Barbara A Friedland

Population Council

$5,106,830
Attributed
$9,020,604
Total exposure
5
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.7M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,020,604 · 5

By mechanism

R01$4,713,005 · 1
P50$3,401,852 · 2
R34$899,747 · 1
R13$6,000 · 1

Top collaborators

Most similar at Population Council

Same institution · by research overlap

Others in their field

Top investigators on “Interview

Research focus

InterviewPregnancyContraceptive MethodsAdherenceQuestionnairesPreferenceUnintended PregnancyCross-Over StudiesContraceptive AgentsWomanPreventCollaborationsPreventionVaginal RingDesignFormulationTechnologyMeasurementFutureProduct DevelopmentSex BehaviorExcisionDoseExperimental Study

Grant awards (15)

Investigating end-user perspectives to inform the development of a novel non-hormonal intravaginal ring to prevent pregnancy and sexually transmitted infections$905,977
P50 · FY2025 · HD · contact PI
Investigating end-user perspectives to inform the development of a novel non-hormonal intravaginal ring to prevent pregnancy and sexually transmitted infections$864,345
P50 · FY2024 · HD · contact PI
An Etonogestrel/Ethinyl Estradiol/QGriffithsin (ETG/EE/QGRFT) IVR to Prevent Pregnancy and HIV$805,684
R01 · FY2024 · AI
An Etonogestrel/Ethinyl Estradiol/QGriffithsin (ETG/EE/QGRFT) IVR to Prevent Pregnancy and HIV$857,028
R01 · FY2023 · AI
Investigating end-user perspectives to inform the development of a novel non-hormonal intravaginal ring to prevent pregnancy and sexually transmitted infections$772,153
P50 · FY2023 · HD · contact PI
Combining PrEP with contraception: a pilot test of an intervention to increase adherence to PrEP in adolescent girls and young women in Zimbabwe$119,473
R34 · FY2023 · MH · contact PI
An Etonogestrel/Ethinyl Estradiol/QGriffithsin (ETG/EE/QGRFT) IVR to Prevent Pregnancy and HIV$987,021
R01 · FY2022 · AI
Investigating end-user perspectives to inform the development of a novel non-hormonal intravaginal ring to prevent pregnancy and sexually transmitted infections$739,009
P50 · FY2022 · HD · contact PI
An Etonogestrel/Ethinyl Estradiol/QGriffithsin (ETG/EE/QGRFT) IVR to Prevent Pregnancy and HIV$994,388
R01 · FY2021 · AI
Combining PrEP with contraception: a pilot test of an intervention to increase adherence to PrEP in adolescent girls and young women in Zimbabwe$174,024
R34 · FY2021 · MH · contact PI
Investigating end-user perspectives to inform the development of a novel non-hormonal intravaginal ring to prevent pregnancy and sexually transmitted infections$120,368
P50 · FY2021 · HD · contact PI
An Etonogestrel/Ethinyl Estradiol/QGriffithsin (ETG/EE/QGRFT) IVR to Prevent Pregnancy and HIV$1,068,884
R01 · FY2020 · AI
Combining PrEP with contraception: a pilot test of an intervention to increase adherence to PrEP in adolescent girls and young women in Zimbabwe$325,011
R34 · FY2020 · MH · contact PI
Combining PrEP with contraception: a pilot test of an intervention to increase adherence to PrEP in adolescent girls and young women in Zimbabwe$281,239
R34 · FY2019 · MH · contact PI
Workshop on Informed Consent in HIV Prevention Trials$6,000
R13 · FY2005 · HD